Despite long-chain PEG modification, tumor uptake in athymic mice with HER2-overexpressing MDA-MB-361 human BC xenografts was limited (1.2% ID/g) at 48 h post-intravenous injection. This evidence concerns the gene ERBB2 and breast cancer.